Background: Insulin signaling regulates luteinizing hormone (LH) production in pituitary gonadotrope cells through unknown mechanisms. Results: FOXO1 phosphorylation and cellular localization are regulated by insulin signaling, and FOXO1 represses LH ␤-subunit (Lhb) transcription. Conclusion: Our study highlights a novel mechanism for regulation of Lhb gene expression. Significance: FOXO1 may act as a metabolic sensor in controlling LH levels and fertility.
LH
2 regulates critical aspects of reproduction, including steroidogenesis and ovulation (1) (2) (3) . It is produced by gonadotropes within the anterior pituitary and secreted into the blood stream as a result of pulsatile GnRH activation of the GnRH receptor (4 -6) . LH is a heterodimeric glycoprotein composed of an ␣ subunit and a unique ␤ subunit (7) . Transcription of the ␤ subunit is the rate-limiting step for LH production and is essential for reproduction (8, 9) . Decreased Lhb mRNA levels result in infertility due to hypogonadotropic hypogonadism, whereas increased Lhb gene expression, such as in the LH␤CTP transgenic mouse model, result in infertility due to anovulation (1, 10) .
Basal transcription of Lhb occurs upon the binding of specificity protein 1 (SP1), SF1, and PTX1 transcription factors to response elements in the Lhb promoter (for review, see Ref. 11) . GnRH signaling via protein kinase C and mitogen-activated protein kinase pathways (12) (13) (14) (15) (16) results in increased synthesis of EGR1 (17, 18) . EGR1 binds to the promoter and interacts in a synergistic manner with SP1, SF1, and PTX1 to up-regulate Lhb gene expression (19, 20) . Activin also induces Lhb synthesis via the binding of SMA/mothers against decapentaplegic (SMAD) transcription factors to the proximal Lhb promoter (21) (22) (23) .
In addition to GnRH and activin, other peptide hormones and growth factors may regulate LH production. The receptors for insulin, insulin-like growth factor 1, and epidermal growth factor as well as downstream components of their signaling pathways are present in gonadotrope cells (24 -27) . A recent study demonstrated that pituitary insulin signaling may play an important role in obesity-related infertility (28) . Although insulin has been shown to increase Lhb gene expression and LH secretion in immortalized gonadotrope cells and in primary pituitary cultures (24, 29 -32) , the mechanisms by which insulin modulates LH production at the level of the gonadotrope remain unclear.
One possibility is that insulin regulates Lhb transcription in gonadotropes via the FOXO subfamily of forkhead transcription factors. The activity of FOXOs is tightly controlled by posttranslational modifications including phosphorylation, acetylation, and ubiquitination (33) . Insulin/growth factor signaling has been shown to negatively regulate FOXOs through phosphorylation by AKT, resulting in their active nuclear export and inhibition of their transcriptional activities (34) . Phosphorylation of FOXOs by other kinases, such as c-Jun N-terminal kinase, in response to stress results in their translocation to the nucleus (35, 36) . Studies have also demonstrated that FOXO can be acetylated by cAMP-response element-binding protein (CREB)-binding protein (CBP)/p300 and deacetylation by sirtuins such as SIRT1 (37, 38) .
FOXOs are the mammalian orthologs of DAF-16, which regulates longevity, metabolism, and fertility in the nematode Caenorhabditis elegans. The FOXO family is composed of four members including FOXO1, FOXO3, FOXO4, and FOXO6 (39, 40) . FOXOs regulate diverse cell functions, such as cell cycle progression, apoptosis, stress resistance, and metabolism (41, 42) . Because disruption of the FOXO1 gene in mice results in embryonic lethality, the role of FOXO1 in the regulation of reproduction is unknown (43) . Although disruption of FOXO4 has no overt phenotype, FOXO3 null mice have an age-dependent reduction in fertility caused by defective follicular growth in the ovary similar to premature ovarian failure in women (44) . In addition to genetic analyses, mechanistic studies have established a role for FOXOs in reproductive tissues, such as the ovary and uterus (45) (46) (47) (48) (49) (50) (51) (52) , but the function of FOXOs in the neuroendocrine control of reproduction remains to be elucidated.
Given that insulin has been reported to regulate Lhb gene expression and that FOXOs are downstream effectors of insulin signaling, the purpose of this study was to determine whether FOXOs can regulate Lhb transcription. We demonstrate that FOXO1 is expressed in adult mouse gonadotrope cells in vivo and that insulin signaling can regulate FOXO1 phosphorylation and cellular localization in an immortalized gonadotrope-derived cell line. More importantly, we show that overexpression of FOXO1 in L␤T2 cells resulted in suppression of basal and GnRH-induced Lhb synthesis.
EXPERIMENTAL PROCEDURES
Antibodies-Rabbit anti-rat LHB (anti-r␤LH-IC-3), guinea pig anti-rat LHB (anti-r␤LH-IC-2) and guinea pig anti-rat thyroid stimulating hormone ␤-subunit (TSHB) antibodies were provided by Dr. A. Immunohistochemistry (IHC)-Adult mouse pituitary tissue sections embedded in paraffin (Zyagen, San Diego, CA) were dewaxed with xylene washes, rehydrated through a series of graded ethanol baths, and washed in H 2 O. The sections were immersed in 10 mM sodium citrate, pH 6.0, heated in a standard microwave twice for 5 min, and allowed to cool for 20 min at room temperature. After washing in water, sections were incubated in 0.3% hydrogen peroxide for 10 min to quench endogenous peroxidase and then washed in 1ϫ phosphate buffered saline (PBS). The sections were blocked in 5% goat serum (Vector Laboratories, Burlingame, CA), 0.3% Triton X-100, PBS for 60 min at room temperature. The primary antibodies used were rabbit anti-rat LHB (1:1000 dilution in 5% goat serum, 0.3% Triton X-100, PBS) and rabbit anti-human FOXO1 (1:100). Biotinylated goat anti-rabbit or anti-rat IgG (Vector Laboratories, 1:300) were used as secondary antibodies, and proteins were visualized using the Vectastain ABC Elite and VIP peroxidase substrate kits (Vector Laboratories). Sections were then counterstained with methyl green (Vector Laboratories), destained in water, immersed in a 0.05% acetic acid, acetone solution, rehydrated with a series of ethanol and xylene baths, and coverslips were mounted using Vectamount (Vector Laboratories). Sections were viewed using a Nikon Eclipse E800 microscope (Nikon, Tokyo, Japan). Digital images were collected using a Nikon Digital Sight camera (DS-Fi1) and analyzed with Version 2.3 NIS-elements image analysis system.
Immunofluorescence (IF)-Adult mouse pituitary tissue sections were rehydrated and processed for antigen retrieval as described above. Dual-fluorescence labeling was performed on the same section with a guinea pig anti-rat LHB (1:200 dilution) or TSHB primary antibody (1:2000 dilution in 10% goat serum, 0.3% Triton X-100) plus a rabbit anti-human FOXO1 primary antibody (1:100) for 48 h at 4°C. The sections were incubated with goat anti-guinea pig IgG Texas Red (Abcam, ab6906; 1:300) and goat anti-rabbit IgG FITC (Vector Laboratories, FI-1000; 1:300) secondary antibodies for 60 min at room temperature. Coverslips were mounted using Vectashield HardSet mounting media with DAPI (Vector Laboratories). Sections were viewed using a Nikon Eclipse TE 2000-U inverted fluorescence microscope. Digital images were collected using a Sony CoolSNAP EZ cooled CCD camera (Roper Scientific, Trenton, NJ) and analyzed with Version 2.3 NIS-elements image analysis system.
␤-Gal Staining of Lhb-Cre x Rosa26
Pituitaries-Heterozygous gonadotrope-specific Lhb-Cre mice (53) were crossed with homozygous Rosa26 mice containing a Cre-responsive ␤-gal reporter gene (54) . Mice were housed in a vivarium animal facility under a 12-h light-dark cycle and provided with food and water ad libitum. All procedures were approved by the University of California, San Diego Institutional Animal Care and Use Committee. Mice were anesthetized with isofluorane and decapitated, and their pituitaries were removed for analysis. Pituitaries were fixed in 4% paraformaldehyde for 1 h, washed with PBS, and incubated overnight at 37°C with 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl ␤-D-galactoside), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl 2 , PBS. The pituitaries were then washed with PBS, incubated overnight with 70% EtOH at 4°C, and embedded in paraffin. 7-m-thick sections were processed for IHC using a rabbit anti-human FOXO1 primary antibody (1:100), as described above.
Tissue Cell Culture-Cell culture was performed using ␣T1-1, ␣T3-1, and L␤T2 cell lines (55, 56) . The ␣T1-1 cells represent a precursor to the gonadotrope/thyrotrope lineages as they express pituitary glycoprotein hormone ␣ subunit (CGA), whereas the ␣T3-1 cells represent a precursor to the gonadotrope lineage because they express CGA, the GnRH receptor, and SF1 but not LHB and FSHB. The L␤T2 cell line has many characteristics of a mature, differentiated gonadotrope (57, 58) . CV-1 cells, a monkey kidney cell line that does not express detectable levels of SF1 or PTX1 (59, 60) , were also used. The cells were maintained in 10-cm plates in DMEM (Dulbecco's modification of Eagle's medium) from Mediatech Inc., (Herndon, VA) with 10% fetal bovine serum (Omega Scientific, Inc., Tarzana, CA) and penicillin/streptomycin antibiotics (Invitrogen) at 37°C and 5% CO 2 . ␣T1-1 cells were maintained on 10-cm plates treated with Matrigel (1:30 dilution). 1ϫ trypsin-EDTA (Sigma) was used for cell dissociation.
Western Blot Analysis-Before hormone treatment, L␤T2 cells were switched to serum-free DMEM containing 0.1% BSA, 5 mg/liter transferrin, and 50 mM sodium selenite. After overnight starvation in serum-free media, the cells were pretreated for 1 h with vehicle (DMSO) or 50 M LY294002 (EMD Biosciences, San Diego, CA) then treated for 10 min with vehicle (0.1% BSA), 1-100 nM insulin (Sigma), 50 M LY294002, or 10 nM insulin and 50 M LY294002. Cells were harvested by incubating in a lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40 (Nonidet P-40), 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, complete protease inhibitor mixture pellet (Roche Applied Science) and phosphatase inhibitor mixture pellet (Roche Applied Science) for 10 min at 4°C. The protein concentration was determined with Bradford reagent (Bio-Rad), and an equal amount of protein per sample was loaded on a 10% SDS-PAGE gel. Proteins were resolved by electrophoresis and transferred for 2 h at 100 V onto polyvinylidene difluoride (Millipore, Billerica, MA) in 1ϫ Tris-glycine, 20% methanol. Blots were blocked for 1 h in 5% milk, then probed overnight at 4°C with rabbit anti-human FOXO1 (1:1000 in blocking buffer), rabbit anti-human phospho-FOXO1 (Ser-256) (1:1000), or anti-human ␤-Tubulin (1:500). Blots were then incubated with an anti-rabbit horseradish peroxidase-linked secondary antibody (Santa Cruz Biotechnology), and bands were visualized using the Western Lightning Plus enhanced chemiluminescence substrate (PerkinElmer Life Sciences).
Immunofluorescence of Cultured Cells-L␤T2 cells were plated onto poly L-lysine coverslips (BD Biosciences, 354085). After 24 h the media were changed to serum-free media for overnight serum starvation. The next morning cells were pretreated for 30 min with vehicle (DMSO) or 50 M LY294002 then treated for 30 min with DMSO, 10 nM insulin, 50 M LY294002, or 10 nM insulin and 50 M LY LY294002. Cells were then washed twice with PBS and fixed with 4% paraformaldehyde for 10 min. Cells were washed in PBS twice and permeabilized with Nonidet P-40 solution (PBS containing 0.2% Nonidet P-40, 20% goat serum, 1% BSA) for 1 h at room temperature. Cells were washed twice in PBS and incubated with FOXO1 primary antibody (1:100) in blocking buffer (PBS containing 20% goat serum, 1% BSA) for 48 h at 4°C. Cells were washed 3 times with PBS for 5 min and incubated with Alexa594-conjugated goat anti-rabbit secondary antibody (Invitrogen, A-11012) (1:400) in blocking buffer for 1 h at room temperature. Cells were washed 3 times with PBS for 5 min, coverslips were mounted, and the cells were imaged as described above for IF.
Plasmid Constructs-The pcDNA3 FLAG human FOXO1, pcDNA3 FLAG FOXO1-CA, pALTER FOXO1-CA, and pALTER FOXO1-CA ϩ mut DBD (W209G/H215L) expression vectors and 3xIRS-luciferase (luc) were previously described (61) . We obtained the pcDNA3 FOXO1-⌬DBD (⌬208 -220) from Dr. William Sellers (Addgene plasmid 10694). The pcDNA3 mouse PTX1 expression vector was also described previously (62) . The pCMV rat EGR1 and mouse SF1 were kindly provided by Dr. Jacques Drouin and Dr. Bon-chu Chung, respectively. The Ϫ1800 rat Lhb-luc reporter in pGL3 was provided by Dr. Mark Lawson. Construction of 5Ј truncations of the Ϫ1800 Lhb-luc reporter plasmid (Ϫ500, Ϫ300, Ϫ150, Ϫ87) was previously described (63) . The Ϫ1068/ϩ9 human LHB-luc reporter in pA3 was generously provided by Dr. Daniel Bernard.
Transient transfection-L␤T2 cells were seeded at 3 ϫ 10 L␤T2 cells were switched to serum-free DMEM containing 0.1% BSA, 5 mg/liter transferrin, and 50 mM sodium selenite 6 h after transfection. After overnight starvation in serumfree media, the cells were treated with vehicle (0.1% BSA) or 10 nM GnRH (Sigma) for 6 h. Luciferase and ␤-Galactosidase Assays-To harvest the cells, they were washed with 1ϫ PBS and lysed with 0.1 M potassium phosphate buffer, pH 7.8, containing 0.2% Triton X-100. Lysed cells were assayed for luc activity using a buffer containing 100 mM Tris-HCl pH 7.8, 15 mM MgSO 4 , 10 mM ATP, and 65 M luciferin. ␤-Gal activity was assayed using the Tropix Galactolight assay (Applied Biosystems, Foster City, CA) according to the manufacturer's protocol. Both assays were measured using a Veritas Microplate Luminometer (Promega, Madison, WI).
Adenoviral Infection-Adenoviral vectors containing cDNA of green fluorescent protein (Ad-GFP) and constitutively active FOXO1 (T24A/S256A/S319A) (Ad-FOXO1-CA) were generously provided by Dr. Domenico Accili. L␤T2 cells were seeded at 2 ϫ 10 6 cells/well on 6-well plates. The next morning cells were transduced with a multiplicity of infection of 200 of Ad-GFP or Ad-FOXO1-CA for 6 h, then switched to serum-free DMEM. 24 h after adenoviral infection, cells were treated with vehicle (0.1% BSA) or 10 M GnRH for 6 h. GFP and FOXO1-CA protein expression was verified by Western blot analysis.
Quantitative RT-PCR-Total RNA was extracted from L␤T2 cells with TRIzol reagent (Invitrogen) following the manufac-turer's protocol. Contaminating DNA was removed with DNAfree reagent (Invitrogen). 2 g of RNA was reverse-transcribed using the iScript cDNA synthesis kit (Bio-Rad) according to the manufacturer's protocol. Quantitative real-time PCR was performed in an iQ5 iCycler using iQ SYBR Green Supermix (BioRad) and the primers Lhb forward, (CTGTCAACG-CAACTCTGG), Lhb reverse (CAGGAGGCAAAGCAGC), Gapdh forward (TGCACCACCAACTGCTTAG), and Gapdh reverse (GGATGCAGGGATGATGTTC) under the following conditions: 95°C for 5 min followed by 40 cycles at 95°C for 45 s, 54°C for 45 s, and 72°C for 45 s. Each sample was assayed in triplicate, and the experiment was repeated four times. Standard curves with dilutions of a plasmid containing Lhb or Gapdh cDNA were generated with the samples in each run. In each experiment, the amount of Lhb and Gapdh was calculated by comparing the threshold cycle obtained for each sample with the standard curve generated in the same run. Replicates were averaged and divided by the mean value of Gapdh in the same sample. After each run, a melting curve analysis was performed to confirm that a single amplicon was generated in each reaction.
Electrophoretic Mobility Shift Assay (EMSA)-FLAG-FOXO1-CA was transcribed and translated using a TNT Coupled Reticulocyte System (Promega). The oligonucleotides were end-labeled with T4 polynucleotide kinase and [␥-32 P]ATP. 4 l of TNT lysate was incubated with 1 fmol of 32 P-labeled oligo at 4°C for 30 min in a DNA binding buffer (10 mM Hepes, pH 7.8, 50 mM KCl, 5 mM MgCl 2 , 0.1% Nonidet P-40, 1 mM dithiothreitol, 2 g of poly(dI-dC), and 10% glycerol). After 30 min, the DNA binding reactions were run on a 5% polyacrylamide gel (30:1 acrylamide:bisacrylamide) containing 2.5% glycerol in a 0.25ϫ Tris borate-EDTA buffer. Mouse anti-FLAG M2 antibody (Sigma) was used to supershift FLAG-FOXO1-CA; mouse IgG was used as a control for nonspecific binding. 100ϫ cold oligo was used as a competitor. The following oligonucleotides were used for EMSA: Ϫ150/Ϫ115 (5Ј-CTGGAGCTGGTCCCTGGCTTTTCTGACCTTGTCTG-3Ј); Ϫ122/Ϫ87 (5Ј-TTGTCTGTCTCGCCCCCAAAGAGATT-AGTGTCTAG-3Ј); Ϫ95/Ϫ60, (5Ј-GTGTCTAGGTTACCCAA-GCCTGTAGCCTCTGCTTA-3Ј); Ϫ65/Ϫ30 (5Ј-GCTTAG-TGGCCTTGCCACCCCCACAACCCGCAGGT-3Ј), the consensus forkhead binding element (FBE) (64) (5Ј-CTAGATGGTA-AACAACTGTGACTAGTAGAACACGG-3Ј), and the mutated consensus FBE (5Ј-CTAGATGGTGGGCAACTGTGACTAG-TAGAACACGG-3Ј).
Statistical Analyses-Transient transfections were performed in triplicate, and each experiment was repeated at least three times. The data were normalized for transfection efficiency by expressing luc activity relative to ␤-gal and relative to the empty reporter plasmid to control for hormone effects on the vector DNA. The data were analyzed by Student's t test for independent samples or one-way analysis of variance (ANOVA) followed by post-hoc comparisons with the TukeyKramer honestly significant difference test using the statistical package JMP 9.0 (SAS, Cary, NC). Significant differences were designated as p Ͻ 0.05.
RESULTS

FOXO1 Is Expressed in Gonadotrope
Cells-Using IHC with a primary FOXO1 antibody, we demonstrated that FOXO1 is expressed in a discrete population of cells within the anterior lobe (AL) of the pituitary of adult mice (Fig. 1, A and B) . FOXO1 was not expressed in the posterior lobe (PL). The negative control, lacking primary antibody, showed no staining (Fig. 1C) . We also performed IHC on sections of mouse ovaries using the FOXO1 antibody as a positive control (Fig. 1D ). FOXO1 expression was specifically detected in ovarian granulosa cells (GC), as previously reported (50) .
We then ascertained whether FOXO1 co-localized with LHB-expressing gonadotrope cells. First, we showed that FOXO1 co-localized with LHB-and TSHB-expressing cells in adult mice using dual label IF. The yellow arrow indicates colocalization between FOXO1 and LHB ( Fig. 2A, merge panel) or FOXO1 and TSHB (Fig. 2B, merge panel) , whereas the white arrow indicates cells that express FOXO1 and do not co-localize. Second, we demonstrated that FOXO1 co-localized with ␤-gal produced in LHB-expressing gonadotrope cells in heterozygous Lhb-Cre mice (53) crossed with Rosa26 mice (54) as indicated by the black arrow (Fig. 2C) . The negative control, lacking primary antibody, did not have any peroxidase staining (Fig. 2D) .
FOXO1 Phosphorylation and Cellular Localization Is Regulated by Insulin Signaling in Immortalized Gonadotrope
Cells-After demonstrating in vivo FOXO1 expression in pituitary gonadotrope cells, we determined whether FOXO1 is expressed in immortalized gonadotrope cells. We performed Western blot analysis of whole cell extracts from ␣T1-1, ␣T3-1, and L␤T2 cells with a FOXO1 antibody. As described under "Experimental Procedures," these immortalized cell lines represent a precursor to the gonadotrope/thyrotrope lineages, an immature gonadotrope cell and a mature gonadotrope cell, respectively (55, 56) . FOXO1 was expressed in all three cell lines (Fig. 3A) . Western blot analysis was also used to determine whether insulin signaling results in FOXO1 phosphorylation in L␤T2 cells. Fig. 3B demonstrates that 10 min of 10 and 100 nM insulin treatment resulted in increased phosphorylation of FOXO1 serine 256 compared with vehicle control. In contrast, total FOXO1 or ␤-tubulin protein levels were unaffected by insulin treatment. We also demonstrated that FOXO1 serine 256 phosphorylation induced by insulin was dependent on PI3K signaling using LY294002, an inhibitor of PI3K activity (Fig. 3B) . We then determined whether insulin treatment resulted in a change in endogenous FOXO1 cellular localization in L␤T2 cells using IF. Vehicle treatment of L␤T2 cells after an overnight incubation in serum-free media resulted in FOXO1 localization distributed between the nucleus and cytoplasm (Fig. 3C) . Insulin treatment resulted in predominantly cytoplasmic FOXO1 localization, whereas treatment with LY294002 led to nuclear localization. Co-treatment of LY294002 and insulin prevented FOXO1 export to the cytoplasm and resulted in nuclear localization.
FOXO1 Overexpression Suppresses Basal and GnRH-induced Lhb Transcription-Overexpression of FOXO1 and constitutively active FOXO1-CA (T24A/S256A/S319A) (Fig. 4A ) in L␤T2 cells enhanced transcription of a 3xIRS-luc plasmid (61) containing three copies of a FBE from the IGFBP-1 gene linked to a luc reporter gene (Fig. 4, B and C) . In these experiments, transfection of increasing concentrations of FOXO1 and FOXO1-CA resulted in higher levels of reporter gene expression, indicating that FOXO1 levels did not reach saturation and that the effects were not likely due to supraphysiological levels of FOXO1 in the cells. Intriguingly, when 200 ng of FOXO1 or FOXO1-CA was transiently transfected with the Ϫ1800 rat Lhb promoter linked to a luc reporter gene (rLhb-luc), we observed repression of basal and GnRH-induced Lhb synthesis (Fig. 4, D 
and E).
To ascertain whether FOXO1 can suppress endogenous Lhb transcription, we transduced L␤T2 cells with adenovirus (Ad) expressing FOXO1-CA or GFP and measured Lhb mRNA levels using quantitative RT-PCR. Although basal transcription of Lhb was not significantly altered, we demonstrated that GnRHinduced Lhb gene expression was significantly decreased in cells infected with Ad-FOXO1-CA versus Ad-GFP (Fig. 4F) . These results indicate that FOXO1 can suppress Lhb synthesis in the context of the native chromatin.
The DNA Binding Domain of FOXO1 Is Required for Suppression of Lhb Synthesis-To determine whether FOXO1 repression occurs at the level of the Lhb promoter, we tested whether DNA binding-deficient FOXO1 could still elicit a suppressive response using a deletion in the FOXO1-DNA binding domain (DBD) (⌬208 -220) and a FOXO1-CA with a mutated DBD (Fig. 5A) . We demonstrated that although overexpression of FOXO1 and FOXO1-CA reduced Lhb gene expression, transcription was not suppressed in the presence of the mutated transcription factors. FOXO1-⌬DBD and FOXO1-CA ϩ mut DBD did not alter basal Lhb synthesis (Fig. 5, B and C) , whereas the FOXO1-⌬DBD mutant did not suppress GnRH-induced 
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Lhb gene expression (Fig. 5D) . These results indicate that the DBD of FOXO1 is necessary for FOXO1 repression of Lhb basal transcription and GnRH induction on the Lhb promoter and suggest that FOXO1 exerts an effect by either binding to the Lhb promoter or indirectly through FOXO1 DBD interaction with other transcription factors/cofactors.
FOXO1 Suppression Maps to the Proximal Promoter of Lhb-
We determined which regions of the Lhb promoter were required for FOXO1 suppression using 5Ј truncation analysis of the promoter. Basal transcription and GnRH induction were measured using Ϫ1800, Ϫ500, Ϫ300, Ϫ150, and Ϫ87 Lhb-luc reporter plasmids (Fig. 6A) . The suppressive effect of FOXO1 mapped to the proximal region on the Lhb promoter (Fig. 6B) , which contains binding elements for SF1, PTX1, and EGR1 (11). In particular, FOXO1 suppression of basal Lhb gene A, shown is a schematic illustrating wild-type FOXO1 and constitutively active FOXO1-CA (T24A/S256A/S319A). NES, nuclear export signal; NLS, nuclear localization signal. B and C, the 3xIRS-luc was transiently transfected into L␤T2 cells along with increasing amounts of FOXO1 or FOXO1-CA expression vectors as indicated. Total amount of expression vector was balanced using the empty pcDNA3 vector. The results represent the mean Ϯ S.E. of at least three experiments performed in triplicate and are presented relative to empty vector (EV). * indicates that the induction by FOXO1 or FOXO1-CA is significantly different from the empty vector using one-way ANOVA followed by Tukey's post-hoc test. D and E, the Ϫ1800 rat Lhb-luc reporter was transfected into L␤T2 cells along with 200 ng of pcDNA3 empty vector, FOXO1, or FOXO1-CA (CA) as indicated. After overnight starvation in serum-free media, cells were treated for 6 h with 0.1% BSA vehicle (Veh) or 10 nM GnRH. The results represent the mean Ϯ S.E. of at least three experiments performed in triplicate and are presented as basal transcription relative to EV (D) or-fold GnRH induction relative to the vehicle control (E). * indicates that Lhb-luc transcription is significantly repressed by FOXO1 or FOXO1-CA compared with EV using one-way ANOVA followed by Tukey's post-hoc test. F, Ad-expressing GFP or FOXO1-CA was transduced into L␤T2 cells as indicated. After overnight starvation in serum-free media, cells were treated for 6 h with 0.1% BSA vehicle (Veh) or 10 nM GnRH. The results represent the mean Ϯ S.E. of four experiments performed in triplicate and are presented as Lhb mRNA relative to Gapdh. The letter b indicates that the GnRH induction in the presence of Ad-FOXO1-CA is significantly different using one-way ANOVA followed by Tukey's post-hoc test.
expression mapped to a region between Ϫ150 and Ϫ87 of the promoter as repression was lost with the Ϫ87 Lhb-luc reporter plasmid (Fig. 6C) . In contrast, FOXO1 suppression of GnRH induction was reduced but not abolished with the Ϫ87 Lhb-luc reporter (Fig. 6D) , suggesting that elements present in the 87 base pairs upstream of the transcription start site are important for FOXO1 repression of GnRH-induced Lhb transcription.
FOXO1 Does Not Bind Directly to the Lhb Promoter-EMSA was performed to assess whether FOXO1 can bind to the proximal Lhb promoter in vitro. Four 35-mer oligonucleotide probes were designed to span the Ϫ150/Ϫ30 region. FLAG-FOXO1-CA, synthesized with TNT rabbit reticulocyte lysate, bound to an oligonucleotide probe containing a consensus FBE (Fig. 7, A and B, lanes 1) but not to probes encompassing the Ϫ150/Ϫ30 region of the Lhb promoter (Fig. 7A, lanes 4, 7, 10,  and 13) . TNT FLAG-FOXO1 also bound to a consensus FBE (data not shown). To identify which complex contained the FLAG-FOXO1-CA bound to the FBE, we supershifted the complex with an anti-FLAG antibody (Fig. 7, A and B, lanes 3) but not with IgG (Fig. 7, A and B, lanes 2) . This complex was not present when rabbit reticulocyte lysate containing the pcDNA3 empty vector was used (data not shown). This complex also showed evidence of self-competition (Fig. 7B, lane 4) but did not compete with a mutated consensus FBE (Fig. 7B, lane 5) . Incubation with oligos encompassing the Ϫ150/Ϫ30 region of the Lhb promoter did not result in competition (Fig. 7B, lanes  6 -9) , indicating that FOXO1 does not bind directly to the proximal Lhb promoter.
FOXO1 Suppression Involves SF1, PTX1, and EGR1-We examined the role of EGR1 in FOXO1 repression of GnRHinduced Lhb synthesis by determining whether Lhb transcription due to EGR1 overexpression in L␤T2 cells was reduced by FOXO1. Overexpression of EGR1 in L␤T2 cells resulted in a 5.3-fold induction of the Lhb promoter that was suppressed 51 or 81% by overexpression of FOXO1 or FOXO1-CA, respectively (Fig. 8A) . Because L␤T2 cells contain abundant amounts of SF1 and PTX1, we also performed transient transfection experiments in CV-1 cells lacking these transcription factors (59, 60) . Overexpression of SF1, PTX1, or EGR1 by themselves did not result in a significant induction of Lhb gene expression (Fig. 8B) . However, coexpression of EGR1 with either SF1 or PTX1 increased Lhb synthesis in CV-1 cells by 4.8-and 3.7-fold, respectively, whereas FOXO1-CA reduced this induction by 52 and 71% (Fig. 8B) .
FOXO1 Suppresses Human LHB Synthesis-Given that the SF1, PTX1, and EGR1 elements in the proximal Lhb promoter β FIGURE 6. FOXO1 suppression maps to the proximal Lhb promoter. A, a schematic illustrates the location of binding elements for SP1, SF1, EGR1, and PTX1 transcription factors. B-D, the Ϫ1800, Ϫ500, Ϫ300, Ϫ150, and Ϫ87 Lhb-luc reporters were transiently transfected into L␤T2 cells along with pcDNA3 empty vector (EV) or FOXO1 as indicated. After overnight starvation in serum-free media, cells were treated for 6 h with 0.1% BSA vehicle (Veh) or 10 nM GnRH. The results represent the mean Ϯ S.E. of at least three experiments performed in triplicate and are presented as luc/␤-gal (B), basal transcription relative to empty vector (C), or -fold GnRH induction relative to the vehicle control (D). * indicates that Lhb-luc transcription is significantly repressed by FOXO1 compared with EV using one-way ANOVA followed by Tukey's post-hoc test.
are highly conserved between mice and humans (20), we hypothesized that FOXO1 would have a similar repressive effect on the human LHB promoter as the murine promoter. When 200 ng of FOXO1 was transiently transfected with the Ϫ1068/ϩ9 human LHB promoter linked to a luciferase reporter gene (hLHB-luc), we observed repression of basal and GnRH-induced Lhb synthesis (Fig. 9, A and B) . Basal Lhb transcription was reduced 79% by FOXO1, whereas GnRH-induced LHB gene expression was reduced by 87%.
DISCUSSION
Although FOXO1 has been shown to be expressed in reproductive tissues such as the ovary and uterus (65) , this is the first report that FOXO1 is expressed in adult murine anterior pituitary. Co-localization of FOXO1 with LHB-and TSHB-expressing cells demonstrated that FOXO1 expression occurred in gonadotropes and thyrotropes. Co-localization of FOXO1 and CGA (present only in gonadotrope and thyrotrope cells within the pituitary) provides supporting evidence that FOXO1 expression is restricted to these two pituitary cell types.
3
FOXO1 is considered to be a relatively ubiquitously expressed protein (66, 67) , although there are many instances where FOXO1 expression is restricted to a specific cell type. For example, FOXO1 is highly expressed in granulosa cells of proliferating follicles but not in adjacent cells within the ovary (48, 50) . FOXO1 is also expressed at high levels in POMC and NPY/ AgRP neurons in the arcuate nucleus of the hypothalamus (68). Our results indicate that future studies investigating the function of FOXO1 in thyrotrope cells as well as the pituitary cell type-specific regulation of FOXO1 gene expression may be informative.
After demonstrating that FOXO1 is expressed in gonadotrope cells in vivo, we also showed that the FOXO1 protein can be detected in immortalized gonadotrope-derived cell lines, in agreement with a previous study (26) . We then investigated whether FOXO1 is a target of insulin signaling in gonadotropes, as previously reported for IRS1/2 and AKT (24, 27) . Our results showed that insulin treatment of L␤T2 cells increased FOXO1 serine 256 phosphorylation and cytoplasmic localization. These data are in agreement with a previous study that showed IGF-1 signaling increased FOXO1 phosphorylation in ␣T3-1 cells (26) . We also used the PI3K inhibitor LY294002 to demonstrate that regulation of FOXO1 phosphorylation and cellular localization by insulin signaling in L␤T2 cells was dependent on PI3K, which is consistent with the insulin effect on FOXO1 in other tissues (33) .
Our studies in L␤T2 cells also demonstrated that FOXO1 may regulate fertility through modulation of Lhb transcription, the rate-limiting step in the production of the mature hormone (8, 9) . Overexpression of wild-type and constitutively active FOXO1 reduced basal and GnRH-induced Lhb-luc expression, whereas overexpression of FOXO1-CA decreased endogenous GnRH-induced Lhb mRNA levels. Our results also indicate that FOXO1 regulation of LH levels may be conserved among mammals as FOXO1 suppressed transcription of both the murine and human LHB promoters. The modulation of Lhb by FOXO1 in L␤T2 cells does not occur because of a general repressive mechanism as the 3xIRS-luc reporter plasmid is not repressed by FOXO1. Rather, FOXO1 suppression of Lhb appears to be due to specific elements in the Lhb promoter lacking in the 3xIRS. Although FOXO1 is often portrayed as an activator of transcription such as on the IGFBP-1, phosphoenolpyruvate carboxykinase, and glucose-6-phosphatase catalytic subunit promoters (69, 70) , it can also act as a repressor. For example, when FOXO1, -3, and -4 were knocked out in liver endothelial cells and the mRNA profiles were compared with wild-type cells using microarray analysis, transcription of many genes increased, indicating that FOXOs act as repressors (71) . Many of these genes were confirmed as FOXO target genes using quantitative RT-PCR and chromatin immunoprecipitation. FOXO1 has also been reported to repress transcription of the peroxisome proliferator-activated receptor ␥ (72).
To test whether FOXO1 binding to the Lhb promoter is necessary for FOXO1 suppression, we used FOXO1 with a mutated or deleted DBD and showed that repression of Lhb required the FOXO1 DBD. We also tested whether FOXO1 binds directly to the Lhb promoter. Using EMSA, we showed that in vitro transcribed and translated FOXO1 and FOXO1-CA do not bind to the proximal Ϫ150/Ϫ30 Lhb promoter, although they can bind to an oligo containing a consensus FBE. This is in agreement with in silico analysis of the proximal Lhb promoter, which did not show any putative FBEs. Together, our results indicate that FOXO1 does not bind directly to the Lhb promoter but rather that FOXO1 modulates Lhb gene expression indirectly through interactions between the FOXO1 DBD and other transcription factors/cofactors.
To further our understanding of FOXO1 regulation of Lhb synthesis, we ascertained which regions of the Lhb promoter were necessary for FOXO1 suppression. The SP1/CArG box is apparently not required to elicit FOXO1 repression of basal and GnRH-induced Lhb gene expression because the suppression maps to the proximal promoter, which lacks these elements. That FOXO1 suppression of basal Lhb transcription was lost with the Ϫ87 5Ј truncation suggests FOXO1 requires elements located between Ϫ150/Ϫ87 such as the 5Ј SF1 or PTX1 binding elements. In contrast, the FOXO1 suppression of GnRH-induced Lhb synthesis was reduced with the Ϫ87 5Ј truncation but not abolished, suggesting that FOXO1 affects GnRH induction through elements located in the region downstream of Ϫ87 as well as between Ϫ150/Ϫ87. These regions include SF1, PTX1, and EGR1 binding elements.
In addition to mapping the FOXO1 repression to the proximal Lhb promoter, we also determined whether FOXO1 can elicit a repressive effect though SF1, PTX, and/or EGR1. Our studies demonstrated that FOXO1 could suppress Lhb transcription induced by EGR1 overexpression in L␤T2 cells. Moreover, FOXO1 suppressed Lhb gene expression induced by SF1 and EGR1 or PTX1 and EGR1 overexpression in CV-1 cells. Because we did not observe induction of Lhb when exogenous SF1 or PTX1 was expressed in the CV-1 cells by themselves, we were unable to determine whether these transcription factors are essential for FOXO1 suppression. However, our results do indicate that FOXO1 suppression of Lhb synthesis can occur in the context of either SF1 or PTX1 combined with EGR1. It is interesting to speculate that this may be due to FOXO1 interactions with SF1, PTX1, and/or EGR1, although it is not known whether such interactions can occur. Alternatively, FOXO1 could interact with cofactors that are recruited to the proximal Lhb promoter. For example, ␤-catenin has been reported to act as a coactivator on the Lhb promoter through interactions with SF1 (73) and potentially PTX1 (74) . Because FOXO1 can interact with ␤-catenin (75, 76) , FOXO1 repression of Lhb may be mediated through FOXO1 interaction with ␤-catenin.
It is also possible that FOXO1 exerts a repressive effect on Lhb mRNA levels through transcriptional regulation of transcription factors/cofactors necessary for Lhb gene expression. For instance, FOXO1 has been reported to decrease EGR1 expression in other cells (77) . However, our results indicate that FOXO1 does not require the endogenous SF1, PTX1, or EGR1 promoters to exert its repressive effect as SF1, PTX1, and EGR1 were overexpressed using a heterologous promoter and support the idea that FOXO1 repression is likely due to effects of FOXO1 on the proximal Lhb promoter. Additional studies are needed to determine how interactions among FOXO1, SF1, PTX1, EGR1, and cofactors such as ␤-catenin contribute to the suppression of Lhb gene expression.
Obese women and women with polycystic ovarian syndrome have reduced fertility and increased LH levels (78 -81) . They also have a high prevalence of insulin resistance and hyperinsulinemia (82) . Female mice with diet-induced obesity are also subfertile with elevated LH production and insulin resistance (83) . Interestingly, obese mice with the insulin receptor knocked out in gonadotrope cells displayed a substantial improvement in reproductive function, indicating that pituitary insulin signaling may play an important role in the etiology of obesity-related infertility (28) . If, as our data strongly suggest, FOXO1 is regulated by insulin signaling in gonadotropes and represses Lhb transcription, then it may prove to be an important factor in the regulation of LH production in situations of caloric insufficiency or excess.
In summary, we show that FOXO1 is expressed in vivo in pituitary gonadotropes and that FOXO1 phosphorylation and cellular localization is regulated by insulin signaling in a PI3K-dependent manner in L␤T2 cells. We also demonstrate that FOXO1 suppresses basal transcription and GnRH induction of the Lhb gene, likely through protein-protein interactions between the FOXO1 DBD and transcription factors/cofactors recruited to the proximal Lhb promoter (see model of Lhb repression in Fig. 10 ). Future in vivo studies using mouse knock-out and transgenic models will help elucidate the potential role of FOXO1 as a pituitary metabolic sensor that regulates reproduction. Further research on the function of specific FOXO1 posttranslational modifications in gonadotrope cells is also needed to understand how FOXO1 integrates input from multiple cellular signaling pathways to regulate reproduction under favorable or adverse environmental conditions. 
